Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4724 ARTÍCULOS , VIENDO DEL 3196 AL 3210

Dysfunctional striatal dopamine signaling in Huntington's disease

Koch ET, Raymond LA.

J Neurosci Res. 2019 Dec;97(12):1636-1654. doi: 10.1002/jnr.24495. Epub 2019 Jul 15.

Decoding the Role of Platelets and Related MicroRNAs in Aging and Neurodegenerative Disorders

Espinosa-Parrilla Y, Gonzalez-Billault C, Fuentes E, Palomo I, Alarcón M.

Front Aging Neurosci. 2019 Jul 2;11:151. doi: 10.3389/fnagi.2019.00151. eCollection 2019.

Emergence of Huntington Disease in a Man With a Premorbid Criminal Lifestyle

Hedlund J, Masterman T.

Front Psychiatry. 2019 Jul 2;10:477. doi: 10.3389/fpsyt.2019.00477. eCollection 2019.

The Role of TDP-43 in Military-Relevant TBI and Chronic Neurodegeneration

Heyburn L, Sajja VSSS, Long JB.

Front Neurol. 2019 Jun 27;10:680. doi: 10.3389/fneur.2019.00680. eCollection 2019.

Quantifying deep grey matter atrophy using automated segmentation approaches: A systematic review of structural MRI studies

Pagnozzi AM, Fripp J, Rose SE.

Neuroimage. 2019 Nov 1;201:116018. doi: 10.1016/j.neuroimage.2019.116018. Epub 2019 Jul 15.

Neuroacanthocytosis: a case report of chorea-acanthocytosis

Xiang Y, Li S, Liu X, Li J, Sun Q, Chen Y, Du Y, Wu J.

J Integr Neurosci. 2019 Jun 30;18(2):197-201. doi: 10.31083/j.jin.2019.02.165.

Electroconvulsive Therapy (ECT) for Refractory Psychiatric Symptoms in Huntington's Disease: A Case Series and Review of the Literature

Adrissi J, Nadkarni NA, Gausche E, Bega D.

J Huntingtons Dis. 2019;8(3):291-300. doi: 10.3233/JHD-190361.

Glycation in Huntington's Disease: A Possible Modifier and Target for Intervention

Brás IC, König A, Outeiro TF.

J Huntingtons Dis. 2019;8(3):245-256. doi: 10.3233/JHD-190366.

The interindividual variability of transcranial magnetic stimulation effects: Implications for diagnostic use in movement disorders

Latorre A, Rocchi L, Berardelli A, Bhatia KP, Rothwell JC.

Mov Disord. 2019 Jul;34(7):936-949. doi: 10.1002/mds.27736. Epub 2019 Jun 10.

Sleep in Huntington's disease: a systematic review and meta-analysis of polysomongraphic findings

Zhang Y, Ren R, Yang L, Zhou J, Li Y, Shi J, Lu L, Sanford LD, Tang X.

Sleep. 2019 Oct 9;42(10):zsz154. doi: 10.1093/sleep/zsz154.

DNA repair and neurological disease: From molecular understanding to the development of diagnostics and model organisms

Abugable AA, Morris JLM, Palminha NM, Zaksauskaite R, Ray S, El-Khamisy SF.

DNA Repair (Amst). 2019 Sep;81:102669. doi: 10.1016/j.dnarep.2019.102669. Epub 2019 Jul 8.

Medicinal Chemistry and Therapeutic Potential of Agonists, Antagonists and Allosteric Modulators of A1 Adenosine Receptor: Current Status and Perspectives

Deb PK, Deka S, Borah P, Abed SN, Klotz KN.

Curr Pharm Des. 2019;25(25):2697-2715. doi: 10.2174/1381612825666190716100509.

Acute Hemiballismus as the Presenting Feature of Parietal Lobe Infarction

Patel AR, Patel AR, Desai S.

Cureus. 2019 May 16;11(5):e4675. doi: 10.7759/cureus.4675.

Cerebrovascular and Neurological Disorders: Protective Role of NRF2

Sivandzade F, Bhalerao A, Cucullo L.

Int J Mol Sci. 2019 Jul 12;20(14):3433. doi: 10.3390/ijms20143433.

Post-translational Regulation of GLT-1 in Neurological Diseases and Its Potential as an Effective Therapeutic Target

Peterson AR, Binder DK.

Front Mol Neurosci. 2019 Jul 9;12:164. doi: 10.3389/fnmol.2019.00164. eCollection 2019.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias